The name of this superfamily has been modified since the most recent official CATH+ release (v4_3_0). At the point of the last release, this superfamily was named:
"P-loop containing nucleotide triphosphate hydrolases
".
FunFam 388: Guanine nucleotide-binding protein G(s) subunit al...
Please note: GO annotations are assigned to the full protein sequence rather than individual protein domains. Since a given protein can contain multiple domains, it is possible that some of the annotations below come from additional domains that occur in the same protein, but have been classified elsewhere in CATH.
There are 33 GO terms relating to "molecular function"
The search results have been sorted with the annotations that are found most frequently at the top of the
list. The results can be filtered by typing text into the search box at the top of the table.
GO Term | Annotations | Evidence |
---|---|---|
Adenylate cyclase activator activity GO:0010856
Increases the activity of the enzyme that catalyzes the reaction: ATP = 3',5'-cyclic AMP + diphosphate.
|
53 |
P04896 (/ISS)
P04896 (/ISS)
P16052 (/ISS)
P29797 (/ISS)
P63091 (/ISS)
P63091 (/ISS)
P63091 (/ISS)
P63091 (/ISS)
P63091 (/ISS)
P63091 (/ISS)
(43 more) |
Protein binding GO:0005515
Interacting selectively and non-covalently with any protein or protein complex (a complex of two or more proteins that may include other nonprotein molecules).
|
29 |
P63092 (/IPI)
P63092 (/IPI)
P63092 (/IPI)
P63092 (/IPI)
P63092 (/IPI)
P63092 (/IPI)
P63092 (/IPI)
P63092 (/IPI)
P63092 (/IPI)
P63092 (/IPI)
(19 more) |
GTPase activity GO:0003924
Catalysis of the reaction: GTP + H2O = GDP + phosphate.
|
21 |
P63092 (/TAS)
P63092 (/TAS)
P63092 (/TAS)
P63092 (/TAS)
P63092 (/TAS)
P63092 (/TAS)
P63092 (/TAS)
P63092 (/TAS)
P63092 (/TAS)
P63092 (/TAS)
(11 more) |
G-protein alpha-subunit binding GO:0001965
Interacting selectively and non-covalently with a G-protein alpha subunit. The alpha subunit binds a guanine nucleotide.
|
7 | P63095 (/IPI) P63095 (/IPI) P63095 (/IPI) P63095 (/IPI) P63095 (/IPI) P63095 (/IPI) Q63803 (/IPI) |
G-protein alpha-subunit binding GO:0001965
Interacting selectively and non-covalently with a G-protein alpha subunit. The alpha subunit binds a guanine nucleotide.
|
7 | P63094 (/ISO) P63094 (/ISO) P63094 (/ISO) P63094 (/ISO) P63094 (/ISO) P63094 (/ISO) Q6R0H7 (/ISO) |
GTPase activity GO:0003924
Catalysis of the reaction: GTP + H2O = GDP + phosphate.
|
7 | P63094 (/ISO) P63094 (/ISO) P63094 (/ISO) P63094 (/ISO) P63094 (/ISO) P63094 (/ISO) Q6R0H7 (/ISO) |
Insulin-like growth factor receptor binding GO:0005159
Interacting selectively and non-covalently with the insulin-like growth factor receptor.
|
7 | P63095 (/IPI) P63095 (/IPI) P63095 (/IPI) P63095 (/IPI) P63095 (/IPI) P63095 (/IPI) Q63803 (/IPI) |
Insulin-like growth factor receptor binding GO:0005159
Interacting selectively and non-covalently with the insulin-like growth factor receptor.
|
7 | P63094 (/ISO) P63094 (/ISO) P63094 (/ISO) P63094 (/ISO) P63094 (/ISO) P63094 (/ISO) Q6R0H7 (/ISO) |
GTP binding GO:0005525
Interacting selectively and non-covalently with GTP, guanosine triphosphate.
|
7 | P63095 (/IDA) P63095 (/IDA) P63095 (/IDA) P63095 (/IDA) P63095 (/IDA) P63095 (/IDA) Q63803 (/IDA) |
GTP binding GO:0005525
Interacting selectively and non-covalently with GTP, guanosine triphosphate.
|
7 | P63094 (/ISO) P63094 (/ISO) P63094 (/ISO) P63094 (/ISO) P63094 (/ISO) P63094 (/ISO) Q6R0H7 (/ISO) |
GTP binding GO:0005525
Interacting selectively and non-covalently with GTP, guanosine triphosphate.
|
7 | P63095 (/TAS) P63095 (/TAS) P63095 (/TAS) P63095 (/TAS) P63095 (/TAS) P63095 (/TAS) Q63803 (/TAS) |
Adenylate cyclase activator activity GO:0010856
Increases the activity of the enzyme that catalyzes the reaction: ATP = 3',5'-cyclic AMP + diphosphate.
|
7 | P63094 (/ISO) P63094 (/ISO) P63094 (/ISO) P63094 (/ISO) P63094 (/ISO) P63094 (/ISO) Q6R0H7 (/ISO) |
Protein domain specific binding GO:0019904
Interacting selectively and non-covalently with a specific domain of a protein.
|
7 | P63095 (/IPI) P63095 (/IPI) P63095 (/IPI) P63095 (/IPI) P63095 (/IPI) P63095 (/IPI) Q63803 (/IPI) |
Protein domain specific binding GO:0019904
Interacting selectively and non-covalently with a specific domain of a protein.
|
7 | P63094 (/ISO) P63094 (/ISO) P63094 (/ISO) P63094 (/ISO) P63094 (/ISO) P63094 (/ISO) Q6R0H7 (/ISO) |
G-protein beta-subunit binding GO:0031681
Interacting selectively and non-covalently with a G-protein beta subunit.
|
7 | P63095 (/IDA) P63095 (/IDA) P63095 (/IDA) P63095 (/IDA) P63095 (/IDA) P63095 (/IDA) Q63803 (/IDA) |
G-protein beta-subunit binding GO:0031681
Interacting selectively and non-covalently with a G-protein beta subunit.
|
7 | P63094 (/ISO) P63094 (/ISO) P63094 (/ISO) P63094 (/ISO) P63094 (/ISO) P63094 (/ISO) Q6R0H7 (/ISO) |
Beta-2 adrenergic receptor binding GO:0031698
Interacting selectively and non-covalently with a beta-2 adrenergic receptor.
|
7 | P63095 (/IPI) P63095 (/IPI) P63095 (/IPI) P63095 (/IPI) P63095 (/IPI) P63095 (/IPI) Q63803 (/IPI) |
Beta-2 adrenergic receptor binding GO:0031698
Interacting selectively and non-covalently with a beta-2 adrenergic receptor.
|
7 | P63094 (/ISO) P63094 (/ISO) P63094 (/ISO) P63094 (/ISO) P63094 (/ISO) P63094 (/ISO) Q6R0H7 (/ISO) |
D1 dopamine receptor binding GO:0031748
Interacting selectively and non-covalently with a D1 dopamine receptor.
|
7 | P63095 (/IPI) P63095 (/IPI) P63095 (/IPI) P63095 (/IPI) P63095 (/IPI) P63095 (/IPI) Q63803 (/IPI) |
D1 dopamine receptor binding GO:0031748
Interacting selectively and non-covalently with a D1 dopamine receptor.
|
7 | P63094 (/ISO) P63094 (/ISO) P63094 (/ISO) P63094 (/ISO) P63094 (/ISO) P63094 (/ISO) Q6R0H7 (/ISO) |
Mu-type opioid receptor binding GO:0031852
Interacting selectively and non-covalently with a mu-type opioid receptor.
|
7 | P63095 (/IDA) P63095 (/IDA) P63095 (/IDA) P63095 (/IDA) P63095 (/IDA) P63095 (/IDA) Q63803 (/IDA) |
Mu-type opioid receptor binding GO:0031852
Interacting selectively and non-covalently with a mu-type opioid receptor.
|
7 | P63095 (/IPI) P63095 (/IPI) P63095 (/IPI) P63095 (/IPI) P63095 (/IPI) P63095 (/IPI) Q63803 (/IPI) |
Mu-type opioid receptor binding GO:0031852
Interacting selectively and non-covalently with a mu-type opioid receptor.
|
7 | P63094 (/ISO) P63094 (/ISO) P63094 (/ISO) P63094 (/ISO) P63094 (/ISO) P63094 (/ISO) Q6R0H7 (/ISO) |
Ionotropic glutamate receptor binding GO:0035255
Interacting selectively and non-covalently with an ionotropic glutamate receptor. Ionotropic glutamate receptors bind glutamate and exert an effect through the regulation of ion channels.
|
7 | P63095 (/IPI) P63095 (/IPI) P63095 (/IPI) P63095 (/IPI) P63095 (/IPI) P63095 (/IPI) Q63803 (/IPI) |
Ionotropic glutamate receptor binding GO:0035255
Interacting selectively and non-covalently with an ionotropic glutamate receptor. Ionotropic glutamate receptors bind glutamate and exert an effect through the regulation of ion channels.
|
7 | P63094 (/ISO) P63094 (/ISO) P63094 (/ISO) P63094 (/ISO) P63094 (/ISO) P63094 (/ISO) Q6R0H7 (/ISO) |
Alpha-tubulin binding GO:0043014
Interacting selectively and non-covalently with the microtubule constituent protein alpha-tubulin.
|
7 | P63095 (/IDA) P63095 (/IDA) P63095 (/IDA) P63095 (/IDA) P63095 (/IDA) P63095 (/IDA) Q63803 (/IDA) |
Alpha-tubulin binding GO:0043014
Interacting selectively and non-covalently with the microtubule constituent protein alpha-tubulin.
|
7 | P63094 (/ISO) P63094 (/ISO) P63094 (/ISO) P63094 (/ISO) P63094 (/ISO) P63094 (/ISO) Q6R0H7 (/ISO) |
Alkylglycerophosphoethanolamine phosphodiesterase activity GO:0047391
Catalysis of the reaction: H2O + 1-alkyl-sn-glycero-3-phosphoethanolamine = ethanolamine + 1-alkyl-sn-glycerol 3-phosphate.
|
7 | P63094 (/ISO) P63094 (/ISO) P63094 (/ISO) P63094 (/ISO) P63094 (/ISO) P63094 (/ISO) Q6R0H7 (/ISO) |
Corticotropin-releasing hormone receptor 1 binding GO:0051430
Interacting selectively and non-covalently with the corticotropin-releasing hormone receptor 1 (CRHR1). CRHR1 is the major subtype in the pituitary corticotroph, and mediates the stimulatory actions of corticotropin-releasing hormone on corticotropin hormone secretion. CRHR1 are also located in cortical areas of the brain, cerebellum and limbic system.
|
7 | P63095 (/IPI) P63095 (/IPI) P63095 (/IPI) P63095 (/IPI) P63095 (/IPI) P63095 (/IPI) Q63803 (/IPI) |
Corticotropin-releasing hormone receptor 1 binding GO:0051430
Interacting selectively and non-covalently with the corticotropin-releasing hormone receptor 1 (CRHR1). CRHR1 is the major subtype in the pituitary corticotroph, and mediates the stimulatory actions of corticotropin-releasing hormone on corticotropin hormone secretion. CRHR1 are also located in cortical areas of the brain, cerebellum and limbic system.
|
7 | P63094 (/ISO) P63094 (/ISO) P63094 (/ISO) P63094 (/ISO) P63094 (/ISO) P63094 (/ISO) Q6R0H7 (/ISO) |
Alkylglycerophosphoethanolamine phosphodiesterase activity GO:0047391
Catalysis of the reaction: H2O + 1-alkyl-sn-glycero-3-phosphoethanolamine = ethanolamine + 1-alkyl-sn-glycerol 3-phosphate.
|
6 | P63095 (/IDA) P63095 (/IDA) P63095 (/IDA) P63095 (/IDA) P63095 (/IDA) P63095 (/IDA) |
GTPase activity GO:0003924
Catalysis of the reaction: GTP + H2O = GDP + phosphate.
|
1 | Q14455 (/NAS) |
Adenylate cyclase activator activity GO:0010856
Increases the activity of the enzyme that catalyzes the reaction: ATP = 3',5'-cyclic AMP + diphosphate.
|
1 | Q63803 (/IDA) |
There are 81 GO terms relating to "biological process"
The search results have been sorted with the annotations that are found most frequently at the top of the
list. The results can be filtered by typing text into the search box at the top of the table.
GO Term | Annotations | Evidence |
---|---|---|
Positive regulation of GTPase activity GO:0043547
Any process that activates or increases the activity of a GTPase.
|
37 |
P04896 (/ISS)
P04896 (/ISS)
P16052 (/ISS)
P29797 (/ISS)
P63091 (/ISS)
P63091 (/ISS)
P63091 (/ISS)
P63091 (/ISS)
P63091 (/ISS)
P63091 (/ISS)
(27 more) |
Positive regulation of cAMP-mediated signaling GO:0043950
Any process which activates, maintains or increases the frequency, rate or extent of cAMP-mediated signaling, a series of molecular signals in which a cell uses cyclic AMP to convert an extracellular signal into a response.
|
37 |
P04896 (/ISS)
P04896 (/ISS)
P16052 (/ISS)
P29797 (/ISS)
P63091 (/ISS)
P63091 (/ISS)
P63091 (/ISS)
P63091 (/ISS)
P63091 (/ISS)
P63091 (/ISS)
(27 more) |
Adenylate cyclase-activating adrenergic receptor signaling pathway GO:0071880
The series of molecular signals generated as a consequence of an adrenergic receptor binding to its physiological ligand, where the pathway proceeds with activation of adenylyl cyclase and a subsequent increase in the concentration of cyclic AMP (cAMP).
|
37 |
P04896 (/ISS)
P04896 (/ISS)
P16052 (/ISS)
P29797 (/ISS)
P63091 (/ISS)
P63091 (/ISS)
P63091 (/ISS)
P63091 (/ISS)
P63091 (/ISS)
P63091 (/ISS)
(27 more) |
Adenylate cyclase-activating G protein-coupled receptor signaling pathway GO:0007189
The series of molecular signals generated as a consequence of a G protein-coupled receptor binding to its physiological ligand, where the pathway proceeds through activation of adenylyl cyclase activity and a subsequent increase in the concentration of cyclic AMP (cAMP).
|
31 |
P04896 (/ISS)
P04896 (/ISS)
P16052 (/ISS)
P29797 (/ISS)
P63091 (/ISS)
P63091 (/ISS)
P63091 (/ISS)
P63091 (/ISS)
P63091 (/ISS)
P63091 (/ISS)
(21 more) |
Positive regulation of cold-induced thermogenesis GO:0120162
Any process that activates or increases the frequency, rate or extent of cold-induced thermogenesis.
|
29 |
B0BMW4 (/ISS)
B0BMW4 (/ISS)
B0BMW4 (/ISS)
B0BMW4 (/ISS)
B0BMW4 (/ISS)
B0BMW4 (/ISS)
B4F771 (/ISS)
P63092 (/ISS)
P63092 (/ISS)
P63092 (/ISS)
(19 more) |
Adenylate cyclase-activating G protein-coupled receptor signaling pathway GO:0007189
The series of molecular signals generated as a consequence of a G protein-coupled receptor binding to its physiological ligand, where the pathway proceeds through activation of adenylyl cyclase activity and a subsequent increase in the concentration of cyclic AMP (cAMP).
|
28 |
P63092 (/IDA)
P63092 (/IDA)
P63092 (/IDA)
P63092 (/IDA)
P63092 (/IDA)
P63092 (/IDA)
P63092 (/IDA)
P63092 (/IDA)
P63092 (/IDA)
P63092 (/IDA)
(18 more) |
G protein-coupled receptor signaling pathway GO:0007186
A series of molecular signals that proceeds with an activated receptor promoting the exchange of GDP for GTP on the alpha-subunit of an associated heterotrimeric G-protein complex. The GTP-bound activated alpha-G-protein then dissociates from the beta- and gamma-subunits to further transmit the signal within the cell. The pathway begins with receptor-ligand interaction, or for basal GPCR signaling the pathway begins with the receptor activating its G protein in the absence of an agonist, and ends with regulation of a downstream cellular process, e.g. transcription. The pathway can start from the plasma membrane, Golgi or nuclear membrane (PMID:24568158 and PMID:16902576).
|
21 |
P63092 (/TAS)
P63092 (/TAS)
P63092 (/TAS)
P63092 (/TAS)
P63092 (/TAS)
P63092 (/TAS)
P63092 (/TAS)
P63092 (/TAS)
P63092 (/TAS)
P63092 (/TAS)
(11 more) |
Adenylate cyclase-activating G protein-coupled receptor signaling pathway GO:0007189
The series of molecular signals generated as a consequence of a G protein-coupled receptor binding to its physiological ligand, where the pathway proceeds through activation of adenylyl cyclase activity and a subsequent increase in the concentration of cyclic AMP (cAMP).
|
15 |
P63094 (/IMP)
P63094 (/IMP)
P63094 (/IMP)
P63094 (/IMP)
P63094 (/IMP)
P63094 (/IMP)
P63095 (/IMP)
P63095 (/IMP)
P63095 (/IMP)
P63095 (/IMP)
(5 more) |
Renal water homeostasis GO:0003091
Renal process involved in the maintenance of an internal steady state of water in the body.
|
14 |
P63092 (/TAS)
P63092 (/TAS)
P63092 (/TAS)
P63092 (/TAS)
P63092 (/TAS)
P63092 (/TAS)
P63092 (/TAS)
P63092 (/TAS)
P63092 (/TAS)
P63092 (/TAS)
(4 more) |
Activation of adenylate cyclase activity GO:0007190
Any process that initiates the activity of the inactive enzyme adenylate cyclase.
|
14 |
P63092 (/TAS)
P63092 (/TAS)
P63092 (/TAS)
P63092 (/TAS)
P63092 (/TAS)
P63092 (/TAS)
P63092 (/TAS)
P63092 (/TAS)
P63092 (/TAS)
P63092 (/TAS)
(4 more) |
Adenylate cyclase-activating dopamine receptor signaling pathway GO:0007191
The series of molecular signals generated as a consequence of a dopamine receptor binding to its physiological ligand, where the pathway proceeds with activation of adenylyl cyclase and a subsequent increase in the concentration of cyclic AMP (cAMP).
|
14 |
P63092 (/ISS)
P63092 (/ISS)
P63092 (/ISS)
P63092 (/ISS)
P63092 (/ISS)
P63092 (/ISS)
P63092 (/ISS)
P63092 (/ISS)
P63092 (/ISS)
P63092 (/ISS)
(4 more) |
Sensory perception of smell GO:0007608
The series of events required for an organism to receive an olfactory stimulus, convert it to a molecular signal, and recognize and characterize the signal. Olfaction involves the detection of chemical composition of an organism's ambient medium by chemoreceptors. This is a neurological process.
|
14 |
P63092 (/TAS)
P63092 (/TAS)
P63092 (/TAS)
P63092 (/TAS)
P63092 (/TAS)
P63092 (/TAS)
P63092 (/TAS)
P63092 (/TAS)
P63092 (/TAS)
P63092 (/TAS)
(4 more) |
Positive regulation of GTPase activity GO:0043547
Any process that activates or increases the activity of a GTPase.
|
14 |
P63092 (/IDA)
P63092 (/IDA)
P63092 (/IDA)
P63092 (/IDA)
P63092 (/IDA)
P63092 (/IDA)
P63092 (/IDA)
P63092 (/IDA)
P63092 (/IDA)
P63092 (/IDA)
(4 more) |
Positive regulation of cAMP-mediated signaling GO:0043950
Any process which activates, maintains or increases the frequency, rate or extent of cAMP-mediated signaling, a series of molecular signals in which a cell uses cyclic AMP to convert an extracellular signal into a response.
|
14 |
P63092 (/IDA)
P63092 (/IDA)
P63092 (/IDA)
P63092 (/IDA)
P63092 (/IDA)
P63092 (/IDA)
P63092 (/IDA)
P63092 (/IDA)
P63092 (/IDA)
P63092 (/IDA)
(4 more) |
Intracellular transport GO:0046907
The directed movement of substances within a cell.
|
14 |
P63092 (/NAS)
P63092 (/NAS)
P63092 (/NAS)
P63092 (/NAS)
P63092 (/NAS)
P63092 (/NAS)
P63092 (/NAS)
P63092 (/NAS)
P63092 (/NAS)
P63092 (/NAS)
(4 more) |
Developmental growth GO:0048589
The increase in size or mass of an entire organism, a part of an organism or a cell, where the increase in size or mass has the specific outcome of the progression of the organism over time from one condition to another.
|
14 |
P63092 (/IDA)
P63092 (/IDA)
P63092 (/IDA)
P63092 (/IDA)
P63092 (/IDA)
P63092 (/IDA)
P63092 (/IDA)
P63092 (/IDA)
P63092 (/IDA)
P63092 (/IDA)
(4 more) |
Regulation of insulin secretion GO:0050796
Any process that modulates the frequency, rate or extent of the regulated release of insulin.
|
14 |
P63092 (/TAS)
P63092 (/TAS)
P63092 (/TAS)
P63092 (/TAS)
P63092 (/TAS)
P63092 (/TAS)
P63092 (/TAS)
P63092 (/TAS)
P63092 (/TAS)
P63092 (/TAS)
(4 more) |
Cognition GO:0050890
The operation of the mind by which an organism becomes aware of objects of thought or perception; it includes the mental activities associated with thinking, learning, and memory.
|
14 |
P63092 (/IDA)
P63092 (/IDA)
P63092 (/IDA)
P63092 (/IDA)
P63092 (/IDA)
P63092 (/IDA)
P63092 (/IDA)
P63092 (/IDA)
P63092 (/IDA)
P63092 (/IDA)
(4 more) |
Bone development GO:0060348
The process whose specific outcome is the progression of bone over time, from its formation to the mature structure. Bone is the hard skeletal connective tissue consisting of both mineral and cellular components.
|
14 |
P63092 (/IDA)
P63092 (/IDA)
P63092 (/IDA)
P63092 (/IDA)
P63092 (/IDA)
P63092 (/IDA)
P63092 (/IDA)
P63092 (/IDA)
P63092 (/IDA)
P63092 (/IDA)
(4 more) |
Hair follicle placode formation GO:0060789
The developmental process in which a hair placode forms. An hair follicle placode is a thickening of the ectoderm that will give rise to the hair follicle bud.
|
14 |
P63092 (/IDA)
P63092 (/IDA)
P63092 (/IDA)
P63092 (/IDA)
P63092 (/IDA)
P63092 (/IDA)
P63092 (/IDA)
P63092 (/IDA)
P63092 (/IDA)
P63092 (/IDA)
(4 more) |
Platelet aggregation GO:0070527
The adhesion of one platelet to one or more other platelets via adhesion molecules.
|
14 |
P63092 (/IDA)
P63092 (/IDA)
P63092 (/IDA)
P63092 (/IDA)
P63092 (/IDA)
P63092 (/IDA)
P63092 (/IDA)
P63092 (/IDA)
P63092 (/IDA)
P63092 (/IDA)
(4 more) |
Cellular response to glucagon stimulus GO:0071377
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a glucagon stimulus.
|
14 |
P63092 (/TAS)
P63092 (/TAS)
P63092 (/TAS)
P63092 (/TAS)
P63092 (/TAS)
P63092 (/TAS)
P63092 (/TAS)
P63092 (/TAS)
P63092 (/TAS)
P63092 (/TAS)
(4 more) |
Cellular response to prostaglandin E stimulus GO:0071380
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a prostagladin E stimulus.
|
14 |
P63092 (/ISS)
P63092 (/ISS)
P63092 (/ISS)
P63092 (/ISS)
P63092 (/ISS)
P63092 (/ISS)
P63092 (/ISS)
P63092 (/ISS)
P63092 (/ISS)
P63092 (/ISS)
(4 more) |
Cellular response to catecholamine stimulus GO:0071870
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a catecholamine stimulus. A catecholamine is any of a group of biogenic amines that includes 4-(2-aminoethyl)pyrocatechol
|
14 |
P63092 (/ISS)
P63092 (/ISS)
P63092 (/ISS)
P63092 (/ISS)
P63092 (/ISS)
P63092 (/ISS)
P63092 (/ISS)
P63092 (/ISS)
P63092 (/ISS)
P63092 (/ISS)
(4 more) |
Adenylate cyclase-activating adrenergic receptor signaling pathway GO:0071880
The series of molecular signals generated as a consequence of an adrenergic receptor binding to its physiological ligand, where the pathway proceeds with activation of adenylyl cyclase and a subsequent increase in the concentration of cyclic AMP (cAMP).
|
14 |
P63092 (/IDA)
P63092 (/IDA)
P63092 (/IDA)
P63092 (/IDA)
P63092 (/IDA)
P63092 (/IDA)
P63092 (/IDA)
P63092 (/IDA)
P63092 (/IDA)
P63092 (/IDA)
(4 more) |
Skeletal system development GO:0001501
The process whose specific outcome is the progression of the skeleton over time, from its formation to the mature structure. The skeleton is the bony framework of the body in vertebrates (endoskeleton) or the hard outer envelope of insects (exoskeleton or dermoskeleton).
|
7 | P63094 (/IMP) P63094 (/IMP) P63094 (/IMP) P63094 (/IMP) P63094 (/IMP) P63094 (/IMP) Q6R0H7 (/IMP) |
Tissue homeostasis GO:0001894
A homeostatic process involved in the maintenance of an internal steady state within a defined tissue of an organism, including control of cellular proliferation and death and control of metabolic function.
|
7 | P63094 (/IMP) P63094 (/IMP) P63094 (/IMP) P63094 (/IMP) P63094 (/IMP) P63094 (/IMP) Q6R0H7 (/IMP) |
Positive regulation of protein phosphorylation GO:0001934
Any process that activates or increases the frequency, rate or extent of addition of phosphate groups to amino acids within a protein.
|
7 | P63095 (/IMP) P63095 (/IMP) P63095 (/IMP) P63095 (/IMP) P63095 (/IMP) P63095 (/IMP) Q63803 (/IMP) |
Positive regulation of protein phosphorylation GO:0001934
Any process that activates or increases the frequency, rate or extent of addition of phosphate groups to amino acids within a protein.
|
7 | P63094 (/ISO) P63094 (/ISO) P63094 (/ISO) P63094 (/ISO) P63094 (/ISO) P63094 (/ISO) Q6R0H7 (/ISO) |
Endochondral ossification GO:0001958
Replacement ossification wherein bone tissue replaces cartilage.
|
7 | P63094 (/IMP) P63094 (/IMP) P63094 (/IMP) P63094 (/IMP) P63094 (/IMP) P63094 (/IMP) Q6R0H7 (/IMP) |
Energy reserve metabolic process GO:0006112
The chemical reactions and pathways by which a cell derives energy from stored compounds such as fats or glycogen.
|
7 | P63094 (/IMP) P63094 (/IMP) P63094 (/IMP) P63094 (/IMP) P63094 (/IMP) P63094 (/IMP) Q6R0H7 (/IMP) |
DNA methylation GO:0006306
The covalent transfer of a methyl group to either N-6 of adenine or C-5 or N-4 of cytosine.
|
7 | P63094 (/IMP) P63094 (/IMP) P63094 (/IMP) P63094 (/IMP) P63094 (/IMP) P63094 (/IMP) Q6R0H7 (/IMP) |
Regulation of transcription by RNA polymerase II GO:0006357
Any process that modulates the frequency, rate or extent of transcription mediated by RNA polymerase II.
|
7 | P63095 (/IMP) P63095 (/IMP) P63095 (/IMP) P63095 (/IMP) P63095 (/IMP) P63095 (/IMP) Q63803 (/IMP) |
Regulation of transcription by RNA polymerase II GO:0006357
Any process that modulates the frequency, rate or extent of transcription mediated by RNA polymerase II.
|
7 | P63094 (/ISO) P63094 (/ISO) P63094 (/ISO) P63094 (/ISO) P63094 (/ISO) P63094 (/ISO) Q6R0H7 (/ISO) |
G protein-coupled receptor signaling pathway GO:0007186
A series of molecular signals that proceeds with an activated receptor promoting the exchange of GDP for GTP on the alpha-subunit of an associated heterotrimeric G-protein complex. The GTP-bound activated alpha-G-protein then dissociates from the beta- and gamma-subunits to further transmit the signal within the cell. The pathway begins with receptor-ligand interaction, or for basal GPCR signaling the pathway begins with the receptor activating its G protein in the absence of an agonist, and ends with regulation of a downstream cellular process, e.g. transcription. The pathway can start from the plasma membrane, Golgi or nuclear membrane (PMID:24568158 and PMID:16902576).
|
7 | P63095 (/IMP) P63095 (/IMP) P63095 (/IMP) P63095 (/IMP) P63095 (/IMP) P63095 (/IMP) Q63803 (/IMP) |
G protein-coupled receptor signaling pathway GO:0007186
A series of molecular signals that proceeds with an activated receptor promoting the exchange of GDP for GTP on the alpha-subunit of an associated heterotrimeric G-protein complex. The GTP-bound activated alpha-G-protein then dissociates from the beta- and gamma-subunits to further transmit the signal within the cell. The pathway begins with receptor-ligand interaction, or for basal GPCR signaling the pathway begins with the receptor activating its G protein in the absence of an agonist, and ends with regulation of a downstream cellular process, e.g. transcription. The pathway can start from the plasma membrane, Golgi or nuclear membrane (PMID:24568158 and PMID:16902576).
|
7 | P63094 (/ISO) P63094 (/ISO) P63094 (/ISO) P63094 (/ISO) P63094 (/ISO) P63094 (/ISO) Q6R0H7 (/ISO) |
Adenylate cyclase-activating G protein-coupled receptor signaling pathway GO:0007189
The series of molecular signals generated as a consequence of a G protein-coupled receptor binding to its physiological ligand, where the pathway proceeds through activation of adenylyl cyclase activity and a subsequent increase in the concentration of cyclic AMP (cAMP).
|
7 | P63094 (/ISO) P63094 (/ISO) P63094 (/ISO) P63094 (/ISO) P63094 (/ISO) P63094 (/ISO) Q6R0H7 (/ISO) |
Adenylate cyclase-activating dopamine receptor signaling pathway GO:0007191
The series of molecular signals generated as a consequence of a dopamine receptor binding to its physiological ligand, where the pathway proceeds with activation of adenylyl cyclase and a subsequent increase in the concentration of cyclic AMP (cAMP).
|
7 | P63094 (/IGI) P63094 (/IGI) P63094 (/IGI) P63094 (/IGI) P63094 (/IGI) P63094 (/IGI) Q6R0H7 (/IGI) |
Adenylate cyclase-activating dopamine receptor signaling pathway GO:0007191
The series of molecular signals generated as a consequence of a dopamine receptor binding to its physiological ligand, where the pathway proceeds with activation of adenylyl cyclase and a subsequent increase in the concentration of cyclic AMP (cAMP).
|
7 | P63094 (/ISO) P63094 (/ISO) P63094 (/ISO) P63094 (/ISO) P63094 (/ISO) P63094 (/ISO) Q6R0H7 (/ISO) |
Positive regulation of cell population proliferation GO:0008284
Any process that activates or increases the rate or extent of cell proliferation.
|
7 | P63095 (/IDA) P63095 (/IDA) P63095 (/IDA) P63095 (/IDA) P63095 (/IDA) P63095 (/IDA) Q63803 (/IDA) |
Positive regulation of cell population proliferation GO:0008284
Any process that activates or increases the rate or extent of cell proliferation.
|
7 | P63094 (/ISO) P63094 (/ISO) P63094 (/ISO) P63094 (/ISO) P63094 (/ISO) P63094 (/ISO) Q6R0H7 (/ISO) |
Post-embryonic development GO:0009791
The process whose specific outcome is the progression of the organism over time, from the completion of embryonic development to the mature structure. See embryonic development.
|
7 | P63094 (/IMP) P63094 (/IMP) P63094 (/IMP) P63094 (/IMP) P63094 (/IMP) P63094 (/IMP) Q6R0H7 (/IMP) |
Regulation of signal transduction GO:0009966
Any process that modulates the frequency, rate or extent of signal transduction.
|
7 | P63094 (/ISO) P63094 (/ISO) P63094 (/ISO) P63094 (/ISO) P63094 (/ISO) P63094 (/ISO) Q6R0H7 (/ISO) |
Positive regulation of sodium ion transport GO:0010765
Any process that increases the frequency, rate or extent of the directed movement of sodium ions (Na+) into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.
|
7 | P63095 (/IMP) P63095 (/IMP) P63095 (/IMP) P63095 (/IMP) P63095 (/IMP) P63095 (/IMP) Q63803 (/IMP) |
Positive regulation of sodium ion transport GO:0010765
Any process that increases the frequency, rate or extent of the directed movement of sodium ions (Na+) into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.
|
7 | P63094 (/ISO) P63094 (/ISO) P63094 (/ISO) P63094 (/ISO) P63094 (/ISO) P63094 (/ISO) Q6R0H7 (/ISO) |
Embryonic hindlimb morphogenesis GO:0035116
The process, occurring in the embryo, by which the anatomical structures of the hindlimbs are generated and organized. The hindlimbs are the posterior limbs of an animal.
|
7 | P63094 (/IMP) P63094 (/IMP) P63094 (/IMP) P63094 (/IMP) P63094 (/IMP) P63094 (/IMP) Q6R0H7 (/IMP) |
Multicellular organism growth GO:0035264
The increase in size or mass of an entire multicellular organism, as opposed to cell growth.
|
7 | P63094 (/IMP) P63094 (/IMP) P63094 (/IMP) P63094 (/IMP) P63094 (/IMP) P63094 (/IMP) Q6R0H7 (/IMP) |
Negative regulation of renal sodium excretion GO:0035814
Any process that decreases the amount of sodium excreted in urine over a unit of time.
|
7 | P63095 (/IMP) P63095 (/IMP) P63095 (/IMP) P63095 (/IMP) P63095 (/IMP) P63095 (/IMP) Q63803 (/IMP) |
Negative regulation of renal sodium excretion GO:0035814
Any process that decreases the amount of sodium excreted in urine over a unit of time.
|
7 | P63094 (/ISO) P63094 (/ISO) P63094 (/ISO) P63094 (/ISO) P63094 (/ISO) P63094 (/ISO) Q6R0H7 (/ISO) |
Post-embryonic body morphogenesis GO:0040032
The process in which the anatomical structures of the post-embryonic soma are generated and organized.
|
7 | P63094 (/IMP) P63094 (/IMP) P63094 (/IMP) P63094 (/IMP) P63094 (/IMP) P63094 (/IMP) Q6R0H7 (/IMP) |
Response to drug GO:0042493
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a drug stimulus. A drug is a substance used in the diagnosis, treatment or prevention of a disease.
|
7 | P63094 (/IMP) P63094 (/IMP) P63094 (/IMP) P63094 (/IMP) P63094 (/IMP) P63094 (/IMP) Q6R0H7 (/IMP) |
Positive regulation of GTPase activity GO:0043547
Any process that activates or increases the activity of a GTPase.
|
7 | P63094 (/ISO) P63094 (/ISO) P63094 (/ISO) P63094 (/ISO) P63094 (/ISO) P63094 (/ISO) Q6R0H7 (/ISO) |
Skin development GO:0043588
The process whose specific outcome is the progression of the skin over time, from its formation to the mature structure. The skin is the external membranous integument of an animal. In vertebrates the skin generally consists of two layers, an outer nonsensitive and nonvascular epidermis (cuticle or skarfskin) composed of cells which are constantly growing and multiplying in the deeper, and being thrown off in the superficial layers, as well as an inner vascular dermis (cutis, corium or true skin) composed mostly of connective tissue.
|
7 | P63094 (/IMP) P63094 (/IMP) P63094 (/IMP) P63094 (/IMP) P63094 (/IMP) P63094 (/IMP) Q6R0H7 (/IMP) |
Positive regulation of cAMP-mediated signaling GO:0043950
Any process which activates, maintains or increases the frequency, rate or extent of cAMP-mediated signaling, a series of molecular signals in which a cell uses cyclic AMP to convert an extracellular signal into a response.
|
7 | P63094 (/ISO) P63094 (/ISO) P63094 (/ISO) P63094 (/ISO) P63094 (/ISO) P63094 (/ISO) Q6R0H7 (/ISO) |
Positive regulation of osteoblast differentiation GO:0045669
Any process that activates or increases the frequency, rate or extent of osteoblast differentiation.
|
7 | P63094 (/IMP) P63094 (/IMP) P63094 (/IMP) P63094 (/IMP) P63094 (/IMP) P63094 (/IMP) Q6R0H7 (/IMP) |
Positive regulation of osteoclast differentiation GO:0045672
Any process that activates or increases the frequency, rate or extent of osteoclast differentiation.
|
7 | P63094 (/IMP) P63094 (/IMP) P63094 (/IMP) P63094 (/IMP) P63094 (/IMP) P63094 (/IMP) Q6R0H7 (/IMP) |
Negative regulation of blood pressure GO:0045776
Any process in which the force of blood traveling through the circulatory system is decreased.
|
7 | P63095 (/IMP) P63095 (/IMP) P63095 (/IMP) P63095 (/IMP) P63095 (/IMP) P63095 (/IMP) Q63803 (/IMP) |
Negative regulation of blood pressure GO:0045776
Any process in which the force of blood traveling through the circulatory system is decreased.
|
7 | P63094 (/ISO) P63094 (/ISO) P63094 (/ISO) P63094 (/ISO) P63094 (/ISO) P63094 (/ISO) Q6R0H7 (/ISO) |
Developmental growth GO:0048589
The increase in size or mass of an entire organism, a part of an organism or a cell, where the increase in size or mass has the specific outcome of the progression of the organism over time from one condition to another.
|
7 | P63094 (/ISO) P63094 (/ISO) P63094 (/ISO) P63094 (/ISO) P63094 (/ISO) P63094 (/ISO) Q6R0H7 (/ISO) |
Embryonic cranial skeleton morphogenesis GO:0048701
The process in which the anatomical structures of the cranial skeleton are generated and organized during the embryonic phase.
|
7 | P63094 (/IMP) P63094 (/IMP) P63094 (/IMP) P63094 (/IMP) P63094 (/IMP) P63094 (/IMP) Q6R0H7 (/IMP) |
Cognition GO:0050890
The operation of the mind by which an organism becomes aware of objects of thought or perception; it includes the mental activities associated with thinking, learning, and memory.
|
7 | P63094 (/ISO) P63094 (/ISO) P63094 (/ISO) P63094 (/ISO) P63094 (/ISO) P63094 (/ISO) Q6R0H7 (/ISO) |
Cartilage development GO:0051216
The process whose specific outcome is the progression of a cartilage element over time, from its formation to the mature structure. Cartilage elements are skeletal elements that consist of connective tissue dominated by extracellular matrix containing collagen type II and large amounts of proteoglycan, particularly chondroitin sulfate.
|
7 | P63094 (/IMP) P63094 (/IMP) P63094 (/IMP) P63094 (/IMP) P63094 (/IMP) P63094 (/IMP) Q6R0H7 (/IMP) |
Calcium ion homeostasis GO:0055074
Any process involved in the maintenance of an internal steady state of calcium ions within an organism or cell.
|
7 | P63095 (/IMP) P63095 (/IMP) P63095 (/IMP) P63095 (/IMP) P63095 (/IMP) P63095 (/IMP) Q63803 (/IMP) |
Calcium ion homeostasis GO:0055074
Any process involved in the maintenance of an internal steady state of calcium ions within an organism or cell.
|
7 | P63094 (/ISO) P63094 (/ISO) P63094 (/ISO) P63094 (/ISO) P63094 (/ISO) P63094 (/ISO) Q6R0H7 (/ISO) |
Bone development GO:0060348
The process whose specific outcome is the progression of bone over time, from its formation to the mature structure. Bone is the hard skeletal connective tissue consisting of both mineral and cellular components.
|
7 | P63094 (/ISO) P63094 (/ISO) P63094 (/ISO) P63094 (/ISO) P63094 (/ISO) P63094 (/ISO) Q6R0H7 (/ISO) |
Hair follicle placode formation GO:0060789
The developmental process in which a hair placode forms. An hair follicle placode is a thickening of the ectoderm that will give rise to the hair follicle bud.
|
7 | P63094 (/ISO) P63094 (/ISO) P63094 (/ISO) P63094 (/ISO) P63094 (/ISO) P63094 (/ISO) Q6R0H7 (/ISO) |
Platelet aggregation GO:0070527
The adhesion of one platelet to one or more other platelets via adhesion molecules.
|
7 | P63094 (/ISO) P63094 (/ISO) P63094 (/ISO) P63094 (/ISO) P63094 (/ISO) P63094 (/ISO) Q6R0H7 (/ISO) |
Response to parathyroid hormone GO:0071107
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a parathyroid hormone stimulus.
|
7 | P63094 (/ISO) P63094 (/ISO) P63094 (/ISO) P63094 (/ISO) P63094 (/ISO) P63094 (/ISO) Q6R0H7 (/ISO) |
Cellular response to prostaglandin E stimulus GO:0071380
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a prostagladin E stimulus.
|
7 | P63094 (/ISO) P63094 (/ISO) P63094 (/ISO) P63094 (/ISO) P63094 (/ISO) P63094 (/ISO) Q6R0H7 (/ISO) |
Genetic imprinting GO:0071514
Any process that modulates the frequency, rate or extent of the chemical reactions and pathways involving macromolecules by a mechanism that is mediated by DNA, is mitotically or meiotically heritable, or is stably self-propagated in the cytoplasm of a resting cell, and does not entail a change in DNA sequence.
|
7 | P63094 (/IMP) P63094 (/IMP) P63094 (/IMP) P63094 (/IMP) P63094 (/IMP) P63094 (/IMP) Q6R0H7 (/IMP) |
Cellular response to catecholamine stimulus GO:0071870
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a catecholamine stimulus. A catecholamine is any of a group of biogenic amines that includes 4-(2-aminoethyl)pyrocatechol
|
7 | P63094 (/ISO) P63094 (/ISO) P63094 (/ISO) P63094 (/ISO) P63094 (/ISO) P63094 (/ISO) Q6R0H7 (/ISO) |
Adenylate cyclase-activating adrenergic receptor signaling pathway GO:0071880
The series of molecular signals generated as a consequence of an adrenergic receptor binding to its physiological ligand, where the pathway proceeds with activation of adenylyl cyclase and a subsequent increase in the concentration of cyclic AMP (cAMP).
|
7 | P63094 (/ISO) P63094 (/ISO) P63094 (/ISO) P63094 (/ISO) P63094 (/ISO) P63094 (/ISO) Q6R0H7 (/ISO) |
Positive regulation of cold-induced thermogenesis GO:0120162
Any process that activates or increases the frequency, rate or extent of cold-induced thermogenesis.
|
7 | P63094 (/IMP) P63094 (/IMP) P63094 (/IMP) P63094 (/IMP) P63094 (/IMP) P63094 (/IMP) Q6R0H7 (/IMP) |
Regulation of parathyroid hormone secretion GO:2000828
Any process that modulates the frequency, rate or extent of parathyroid hormone secretion.
|
7 | P63094 (/IMP) P63094 (/IMP) P63094 (/IMP) P63094 (/IMP) P63094 (/IMP) P63094 (/IMP) Q6R0H7 (/IMP) |
Adenylate cyclase-activating dopamine receptor signaling pathway GO:0007191
The series of molecular signals generated as a consequence of a dopamine receptor binding to its physiological ligand, where the pathway proceeds with activation of adenylyl cyclase and a subsequent increase in the concentration of cyclic AMP (cAMP).
|
6 | P63095 (/IDA) P63095 (/IDA) P63095 (/IDA) P63095 (/IDA) P63095 (/IDA) P63095 (/IDA) |
Cellular response to prostaglandin E stimulus GO:0071380
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a prostagladin E stimulus.
|
6 | P63095 (/IDA) P63095 (/IDA) P63095 (/IDA) P63095 (/IDA) P63095 (/IDA) P63095 (/IDA) |
Cellular response to catecholamine stimulus GO:0071870
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a catecholamine stimulus. A catecholamine is any of a group of biogenic amines that includes 4-(2-aminoethyl)pyrocatechol
|
6 | P63095 (/IDA) P63095 (/IDA) P63095 (/IDA) P63095 (/IDA) P63095 (/IDA) P63095 (/IDA) |
Adenylate cyclase-activating G protein-coupled receptor signaling pathway GO:0007189
The series of molecular signals generated as a consequence of a G protein-coupled receptor binding to its physiological ligand, where the pathway proceeds through activation of adenylyl cyclase activity and a subsequent increase in the concentration of cyclic AMP (cAMP).
|
1 | Q14455 (/NAS) |
Developmental growth GO:0048589
The increase in size or mass of an entire organism, a part of an organism or a cell, where the increase in size or mass has the specific outcome of the progression of the organism over time from one condition to another.
|
1 | Q5JWF2 (/IMP) |
Bone development GO:0060348
The process whose specific outcome is the progression of bone over time, from its formation to the mature structure. Bone is the hard skeletal connective tissue consisting of both mineral and cellular components.
|
1 | Q5JWF2 (/IMP) |
Platelet aggregation GO:0070527
The adhesion of one platelet to one or more other platelets via adhesion molecules.
|
1 | Q5JWF2 (/IMP) |
There are 39 GO terms relating to "cellular component"
The search results have been sorted with the annotations that are found most frequently at the top of the
list. The results can be filtered by typing text into the search box at the top of the table.
GO Term | Annotations | Evidence |
---|---|---|
Membrane GO:0016020
A lipid bilayer along with all the proteins and protein complexes embedded in it an attached to it.
|
29 |
P63092 (/IDA)
P63092 (/IDA)
P63092 (/IDA)
P63092 (/IDA)
P63092 (/IDA)
P63092 (/IDA)
P63092 (/IDA)
P63092 (/IDA)
P63092 (/IDA)
P63092 (/IDA)
(19 more) |
Cytosol GO:0005829
The part of the cytoplasm that does not contain organelles but which does contain other particulate matter, such as protein complexes.
|
22 |
P63092 (/IDA)
P63092 (/IDA)
P63092 (/IDA)
P63092 (/IDA)
P63092 (/IDA)
P63092 (/IDA)
P63092 (/IDA)
P63092 (/IDA)
P63092 (/IDA)
P63092 (/IDA)
(12 more) |
Cytoplasm GO:0005737
All of the contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures.
|
21 |
P63092 (/IDA)
P63092 (/IDA)
P63092 (/IDA)
P63092 (/IDA)
P63092 (/IDA)
P63092 (/IDA)
P63092 (/IDA)
P63092 (/IDA)
P63092 (/IDA)
P63092 (/IDA)
(11 more) |
Heterotrimeric G-protein complex GO:0005834
Any of a family of heterotrimeric GTP-binding and hydrolyzing proteins; they belong to a superfamily of GTPases that includes monomeric proteins such as EF-Tu and RAS. Heterotrimeric G-proteins consist of three subunits; the alpha subunit contains the guanine nucleotide binding site and possesses GTPase activity; the beta and gamma subunits are tightly associated and function as a beta-gamma heterodimer; extrinsic plasma membrane proteins (cytoplasmic face) that function as a complex to transduce signals from G protein-coupled receptors to an effector protein.
|
21 |
P63092 (/TAS)
P63092 (/TAS)
P63092 (/TAS)
P63092 (/TAS)
P63092 (/TAS)
P63092 (/TAS)
P63092 (/TAS)
P63092 (/TAS)
P63092 (/TAS)
P63092 (/TAS)
(11 more) |
Plasma membrane GO:0005886
The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins.
|
21 |
P63092 (/TAS)
P63092 (/TAS)
P63092 (/TAS)
P63092 (/TAS)
P63092 (/TAS)
P63092 (/TAS)
P63092 (/TAS)
P63092 (/TAS)
P63092 (/TAS)
P63092 (/TAS)
(11 more) |
Extracellular exosome GO:0070062
A vesicle that is released into the extracellular region by fusion of the limiting endosomal membrane of a multivesicular body with the plasma membrane. Extracellular exosomes, also simply called exosomes, have a diameter of about 40-100 nm.
|
15 |
P63092 (/HDA)
P63092 (/HDA)
P63092 (/HDA)
P63092 (/HDA)
P63092 (/HDA)
P63092 (/HDA)
P63092 (/HDA)
P63092 (/HDA)
P63092 (/HDA)
P63092 (/HDA)
(5 more) |
Heterotrimeric G-protein complex GO:0005834
Any of a family of heterotrimeric GTP-binding and hydrolyzing proteins; they belong to a superfamily of GTPases that includes monomeric proteins such as EF-Tu and RAS. Heterotrimeric G-proteins consist of three subunits; the alpha subunit contains the guanine nucleotide binding site and possesses GTPase activity; the beta and gamma subunits are tightly associated and function as a beta-gamma heterodimer; extrinsic plasma membrane proteins (cytoplasmic face) that function as a complex to transduce signals from G protein-coupled receptors to an effector protein.
|
14 |
P63092 (/ISS)
P63092 (/ISS)
P63092 (/ISS)
P63092 (/ISS)
P63092 (/ISS)
P63092 (/ISS)
P63092 (/ISS)
P63092 (/ISS)
P63092 (/ISS)
P63092 (/ISS)
(4 more) |
Intrinsic component of membrane GO:0031224
The component of a membrane consisting of the gene products having some covalently attached portion, for example part of a peptide sequence or some other covalently attached group such as a GPI anchor, which spans or is embedded in one or both leaflets of the membrane.
|
14 |
P63092 (/IDA)
P63092 (/IDA)
P63092 (/IDA)
P63092 (/IDA)
P63092 (/IDA)
P63092 (/IDA)
P63092 (/IDA)
P63092 (/IDA)
P63092 (/IDA)
P63092 (/IDA)
(4 more) |
Trans-Golgi network membrane GO:0032588
The lipid bilayer surrounding any of the compartments that make up the trans-Golgi network.
|
14 |
P63092 (/IDA)
P63092 (/IDA)
P63092 (/IDA)
P63092 (/IDA)
P63092 (/IDA)
P63092 (/IDA)
P63092 (/IDA)
P63092 (/IDA)
P63092 (/IDA)
P63092 (/IDA)
(4 more) |
Ruffle GO:0001726
Projection at the leading edge of a crawling cell; the protrusions are supported by a microfilament meshwork.
|
7 | P63095 (/IDA) P63095 (/IDA) P63095 (/IDA) P63095 (/IDA) P63095 (/IDA) P63095 (/IDA) Q63803 (/IDA) |
Ruffle GO:0001726
Projection at the leading edge of a crawling cell; the protrusions are supported by a microfilament meshwork.
|
7 | P63094 (/ISO) P63094 (/ISO) P63094 (/ISO) P63094 (/ISO) P63094 (/ISO) P63094 (/ISO) Q6R0H7 (/ISO) |
Nucleus GO:0005634
A membrane-bounded organelle of eukaryotic cells in which chromosomes are housed and replicated. In most cells, the nucleus contains all of the cell's chromosomes except the organellar chromosomes, and is the site of RNA synthesis and processing. In some species, or in specialized cell types, RNA metabolism or DNA replication may be absent.
|
7 | P63094 (/ISO) P63094 (/ISO) P63094 (/ISO) P63094 (/ISO) P63094 (/ISO) P63094 (/ISO) Q6R0H7 (/ISO) |
Cytoplasm GO:0005737
All of the contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures.
|
7 | P63094 (/ISO) P63094 (/ISO) P63094 (/ISO) P63094 (/ISO) P63094 (/ISO) P63094 (/ISO) Q6R0H7 (/ISO) |
Endosome GO:0005768
A vacuole to which materials ingested by endocytosis are delivered.
|
7 | P63095 (/IDA) P63095 (/IDA) P63095 (/IDA) P63095 (/IDA) P63095 (/IDA) P63095 (/IDA) Q63803 (/IDA) |
Endosome GO:0005768
A vacuole to which materials ingested by endocytosis are delivered.
|
7 | P63094 (/ISO) P63094 (/ISO) P63094 (/ISO) P63094 (/ISO) P63094 (/ISO) P63094 (/ISO) Q6R0H7 (/ISO) |
Cytosol GO:0005829
The part of the cytoplasm that does not contain organelles but which does contain other particulate matter, such as protein complexes.
|
7 | P63094 (/ISO) P63094 (/ISO) P63094 (/ISO) P63094 (/ISO) P63094 (/ISO) P63094 (/ISO) Q6R0H7 (/ISO) |
Heterotrimeric G-protein complex GO:0005834
Any of a family of heterotrimeric GTP-binding and hydrolyzing proteins; they belong to a superfamily of GTPases that includes monomeric proteins such as EF-Tu and RAS. Heterotrimeric G-proteins consist of three subunits; the alpha subunit contains the guanine nucleotide binding site and possesses GTPase activity; the beta and gamma subunits are tightly associated and function as a beta-gamma heterodimer; extrinsic plasma membrane proteins (cytoplasmic face) that function as a complex to transduce signals from G protein-coupled receptors to an effector protein.
|
7 | P63095 (/IDA) P63095 (/IDA) P63095 (/IDA) P63095 (/IDA) P63095 (/IDA) P63095 (/IDA) Q63803 (/IDA) |
Heterotrimeric G-protein complex GO:0005834
Any of a family of heterotrimeric GTP-binding and hydrolyzing proteins; they belong to a superfamily of GTPases that includes monomeric proteins such as EF-Tu and RAS. Heterotrimeric G-proteins consist of three subunits; the alpha subunit contains the guanine nucleotide binding site and possesses GTPase activity; the beta and gamma subunits are tightly associated and function as a beta-gamma heterodimer; extrinsic plasma membrane proteins (cytoplasmic face) that function as a complex to transduce signals from G protein-coupled receptors to an effector protein.
|
7 | P63094 (/ISO) P63094 (/ISO) P63094 (/ISO) P63094 (/ISO) P63094 (/ISO) P63094 (/ISO) Q6R0H7 (/ISO) |
Plasma membrane GO:0005886
The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins.
|
7 | P63095 (/IDA) P63095 (/IDA) P63095 (/IDA) P63095 (/IDA) P63095 (/IDA) P63095 (/IDA) Q63803 (/IDA) |
Plasma membrane GO:0005886
The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins.
|
7 | P63094 (/ISO) P63094 (/ISO) P63094 (/ISO) P63094 (/ISO) P63094 (/ISO) P63094 (/ISO) Q6R0H7 (/ISO) |
Membrane GO:0016020
A lipid bilayer along with all the proteins and protein complexes embedded in it an attached to it.
|
7 | P63094 (/IMP) P63094 (/IMP) P63094 (/IMP) P63094 (/IMP) P63094 (/IMP) P63094 (/IMP) Q6R0H7 (/IMP) |
Membrane GO:0016020
A lipid bilayer along with all the proteins and protein complexes embedded in it an attached to it.
|
7 | P63094 (/ISO) P63094 (/ISO) P63094 (/ISO) P63094 (/ISO) P63094 (/ISO) P63094 (/ISO) Q6R0H7 (/ISO) |
COPI-coated Golgi to ER transport vesicle GO:0030142
A vesicle that mediates transport from the Golgi to the endoplasmic reticulum.
|
7 | P63095 (/IDA) P63095 (/IDA) P63095 (/IDA) P63095 (/IDA) P63095 (/IDA) P63095 (/IDA) Q63803 (/IDA) |
COPI-coated Golgi to ER transport vesicle GO:0030142
A vesicle that mediates transport from the Golgi to the endoplasmic reticulum.
|
7 | P63094 (/ISO) P63094 (/ISO) P63094 (/ISO) P63094 (/ISO) P63094 (/ISO) P63094 (/ISO) Q6R0H7 (/ISO) |
Dendrite GO:0030425
A neuron projection that has a short, tapering, morphology. Dendrites receive and integrate signals from other neurons or from sensory stimuli, and conduct nerve impulses towards the axon or the cell body. In most neurons, the impulse is conveyed from dendrites to axon via the cell body, but in some types of unipolar neuron, the impulse does not travel via the cell body.
|
7 | P63094 (/IDA) P63094 (/IDA) P63094 (/IDA) P63094 (/IDA) P63094 (/IDA) P63094 (/IDA) Q6R0H7 (/IDA) |
Intrinsic component of membrane GO:0031224
The component of a membrane consisting of the gene products having some covalently attached portion, for example part of a peptide sequence or some other covalently attached group such as a GPI anchor, which spans or is embedded in one or both leaflets of the membrane.
|
7 | P63094 (/ISO) P63094 (/ISO) P63094 (/ISO) P63094 (/ISO) P63094 (/ISO) P63094 (/ISO) Q6R0H7 (/ISO) |
Trans-Golgi network membrane GO:0032588
The lipid bilayer surrounding any of the compartments that make up the trans-Golgi network.
|
7 | P63094 (/ISO) P63094 (/ISO) P63094 (/ISO) P63094 (/ISO) P63094 (/ISO) P63094 (/ISO) Q6R0H7 (/ISO) |
Neuronal cell body GO:0043025
The portion of a neuron that includes the nucleus, but excludes cell projections such as axons and dendrites.
|
7 | P63095 (/IDA) P63095 (/IDA) P63095 (/IDA) P63095 (/IDA) P63095 (/IDA) P63095 (/IDA) Q63803 (/IDA) |
Neuronal cell body GO:0043025
The portion of a neuron that includes the nucleus, but excludes cell projections such as axons and dendrites.
|
7 | P63094 (/ISO) P63094 (/ISO) P63094 (/ISO) P63094 (/ISO) P63094 (/ISO) P63094 (/ISO) Q6R0H7 (/ISO) |
Membrane raft GO:0045121
Any of the small (10-200 nm), heterogeneous, highly dynamic, sterol- and sphingolipid-enriched membrane domains that compartmentalize cellular processes. Small rafts can sometimes be stabilized to form larger platforms through protein-protein and protein-lipid interactions.
|
7 | P63095 (/IDA) P63095 (/IDA) P63095 (/IDA) P63095 (/IDA) P63095 (/IDA) P63095 (/IDA) Q63803 (/IDA) |
Membrane raft GO:0045121
Any of the small (10-200 nm), heterogeneous, highly dynamic, sterol- and sphingolipid-enriched membrane domains that compartmentalize cellular processes. Small rafts can sometimes be stabilized to form larger platforms through protein-protein and protein-lipid interactions.
|
7 | P63094 (/ISO) P63094 (/ISO) P63094 (/ISO) P63094 (/ISO) P63094 (/ISO) P63094 (/ISO) Q6R0H7 (/ISO) |
Perinuclear region of cytoplasm GO:0048471
Cytoplasm situated near, or occurring around, the nucleus.
|
7 | P63095 (/IDA) P63095 (/IDA) P63095 (/IDA) P63095 (/IDA) P63095 (/IDA) P63095 (/IDA) Q63803 (/IDA) |
Perinuclear region of cytoplasm GO:0048471
Cytoplasm situated near, or occurring around, the nucleus.
|
7 | P63094 (/ISO) P63094 (/ISO) P63094 (/ISO) P63094 (/ISO) P63094 (/ISO) P63094 (/ISO) Q6R0H7 (/ISO) |
Recycling endosome GO:0055037
An organelle consisting of a network of tubules that functions in targeting molecules, such as receptors transporters and lipids, to the plasma membrane.
|
7 | P63095 (/IDA) P63095 (/IDA) P63095 (/IDA) P63095 (/IDA) P63095 (/IDA) P63095 (/IDA) Q63803 (/IDA) |
Recycling endosome GO:0055037
An organelle consisting of a network of tubules that functions in targeting molecules, such as receptors transporters and lipids, to the plasma membrane.
|
7 | P63094 (/ISO) P63094 (/ISO) P63094 (/ISO) P63094 (/ISO) P63094 (/ISO) P63094 (/ISO) Q6R0H7 (/ISO) |
Cytosol GO:0005829
The part of the cytoplasm that does not contain organelles but which does contain other particulate matter, such as protein complexes.
|
1 | Q5JWF2 (/ISS) |
Heterotrimeric G-protein complex GO:0005834
Any of a family of heterotrimeric GTP-binding and hydrolyzing proteins; they belong to a superfamily of GTPases that includes monomeric proteins such as EF-Tu and RAS. Heterotrimeric G-proteins consist of three subunits; the alpha subunit contains the guanine nucleotide binding site and possesses GTPase activity; the beta and gamma subunits are tightly associated and function as a beta-gamma heterodimer; extrinsic plasma membrane proteins (cytoplasmic face) that function as a complex to transduce signals from G protein-coupled receptors to an effector protein.
|
1 | Q14455 (/NAS) |
Membrane GO:0016020
A lipid bilayer along with all the proteins and protein complexes embedded in it an attached to it.
|
1 | Q5JWF2 (/HDA) |
Membrane GO:0016020
A lipid bilayer along with all the proteins and protein complexes embedded in it an attached to it.
|
1 | Q5JWF2 (/ISS) |